{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:01:43Z","timestamp":1789070503028,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Acibadem University Scientific Research Projects Commission","award":["2019\/04-08"],"award-info":[{"award-number":["2019\/04-08"]}]},{"name":"Scientific and Technological Research Council of Turkiye","award":["216S060"],"award-info":[{"award-number":["216S060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent reports on antibiotic resistance have highlighted the need to reduce the impact of this global health issue through urgent prevention and control. The World Health Organization currently considers antibiotic resistance as one of the most dangerous threats to global health. Therefore, Antimicrobial peptides (AMPs) are promising for the development of novel antibiotic molecules due to their high antimicrobial effects, non-inducing antimicrobial resistance (AMR) properties, and broad spectrum. Hence, in this study, we developed novel antimicrobial peptide\/polymer conjugates to reduce the adverse effects of TN6 (RLLRLLLRLLR) peptide. We demonstrate how our constructs function in vitro in terms of antimicrobial activity, hemolytic activity, cytotoxicity, and protease resistance. Our findings show that our molecules are effective against different types of microorganisms such as <jats:italic>Staphylococcus aureus<\/jats:italic>, <jats:italic>Escherichia coli<\/jats:italic>, <jats:italic>Pseudomonas aeruginosa<\/jats:italic>, methicillin-resistant <jats:italic>S. aureus<\/jats:italic>, vancomycin-resistant <jats:italic>Enteroccus faecium<\/jats:italic>, and <jats:italic>Candida albicans<\/jats:italic>, which are known to be pathogenic and antibiotic-resistant. Our constructs generally showed low cytotoxicity relative to the peptide in HaCaT and 3T3 cells. Especially these structures are very successful in terms of hemotoxicity. In the bacteremia model with <jats:italic>S. aureus<\/jats:italic>, the naked peptide (TN6) was hemotoxic even at 1\u00a0\u00b5g\/mL, while the hemotoxicity of the conjugates was considerably lower than the peptide. Remarkably in this model, the hemolytic activity of PepC-PEG-pepC conjugate decreased 15-fold from 2.36 to 31.12\u00a0\u00b5g\/mL compared to the bacteria-free 60-min treatment. This is proof that in the case of bacteremia and sepsis, the conjugates specifically direct to bacterial cell membranes rather than red blood cells. In addition, the PepC-PEG-pepC conjugate is resistant to plasma proteases. Moreover, morphological and intracellular damage of the peptide\/conjugates to <jats:italic>Escherichia coli<\/jats:italic> are demonstrated in SEM and TEM images. These results suggest our molecules can be considered potential next-generation broad-spectrum antibiotic molecule\/drug candidates that might be used in clinical cases such as bacteremia and sepsis.<\/jats:p>","DOI":"10.1038\/s41598-023-38449-3","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T10:02:30Z","timestamp":1689069750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["In vitro efficacy of different PEGylation designs on cathelicidin-like peptide with high antibacterial and antifungal activity"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5482-5217","authenticated-orcid":false,"given":"Seray","family":"Sahsuvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7211-2026","authenticated-orcid":false,"given":"Tanil","family":"Kocagoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-2397","authenticated-orcid":false,"given":"Ozgul","family":"Gok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-2502","authenticated-orcid":false,"given":"Ozge","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"38449_CR1","first-page":"795","volume":"23","author":"C Manyi-Loh","year":"2018","unstructured":"Manyi-Loh, C., Mamphweli, S., Meyer, E. & Okoh, A. Antibiotic use in agriculture and its consequential resistance in environmental sources: Potential public health implications. Mol. J. Synth. Chem. Nat. Prod. Chem. 23, 795 (2018).","journal-title":"Mol. J. Synth. Chem. Nat. Prod. Chem."},{"key":"38449_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","volume":"387","author":"R Laxminarayan","year":"2016","unstructured":"Laxminarayan, R. et al. Access to effective antimicrobials: A worldwide challenge. Lancet Lond. Engl. 387, 168\u2013175 (2016).","journal-title":"Lancet Lond. Engl."},{"key":"38449_CR3","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola, C. L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm. Ther. 40, 277 (2015).","journal-title":"Pharm. Ther."},{"key":"38449_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-022-02167-z","author":"M Prillaman","year":"2022","unstructured":"Prillaman, M. Climate change is making hundreds of diseases much worse. Nature https:\/\/doi.org\/10.1038\/d41586-022-02167-z (2022).","journal-title":"Nature"},{"key":"38449_CR5","doi-asserted-by":"crossref","unstructured":"Le, C. F., Fang, C. M. & Sekaran, S. D. Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob. Agents Chemother. 61, e0234016 (2017).","DOI":"10.1128\/AAC.02340-16"},{"key":"38449_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chemphyslip.2011.09.004","volume":"164","author":"S Riedl","year":"2011","unstructured":"Riedl, S., Zweytick, D. & Lohner, K. Membrane-active host defense peptides: Challenges and perspectives for the development of novel anticancer drugs. Chem. Phys. Lipids 164, 766 (2011).","journal-title":"Chem. Phys. Lipids"},{"key":"38449_CR7","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1007\/s11033-012-1997-x","volume":"39","author":"EM Ko\u015bciuczuk","year":"2012","unstructured":"Ko\u015bciuczuk, E. M. et al. Cathelicidins: Family of antimicrobial peptides: A review. Mol. Biol. Rep. 39, 10957\u201310970 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"38449_CR8","first-page":"3919","volume":"11","author":"J Lei","year":"2019","unstructured":"Lei, J. et al. The antimicrobial peptides and their potential clinical applications. Am. J. Transl. Res. 11, 3919\u20133931 (2019).","journal-title":"Am. J. Transl. Res."},{"key":"38449_CR9","first-page":"315","volume":"22","author":"FM Veronese","year":"2008","unstructured":"Veronese, F. M. & Mero, A. The impact of PEGylation on biological therapies. BioDrugs Clin. Immunother. Biopharm. Gene Ther. 22, 315\u2013329 (2008).","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"38449_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1021\/bm401884e","volume":"15","author":"S Singh","year":"2014","unstructured":"Singh, S., Papareddy, P., M\u00f6rgelin, M., Schmidtchen, A. & Malmsten, M. Effects of PEGylation on membrane and lipopolysaccharide interactions of host defense peptides. Biomacromol 15, 1337\u20131345 (2014).","journal-title":"Biomacromol"},{"key":"38449_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12866-022-02534-w","volume":"22","author":"T Li","year":"2022","unstructured":"Li, T. et al. C-terminal mini-PEGylation of a marine peptide N6 had potent antibacterial and anti-inflammatory properties against Escherichia coli and Salmonella strains in vitro and in vivo. BMC Microbiol. 22, 128 (2022).","journal-title":"BMC Microbiol."},{"key":"38449_CR12","first-page":"6","volume":"4","author":"N Unubol","year":"2017","unstructured":"Unubol, N. et al. Peptide antibiotics developed by mimicking natural antimicrobial peptides. Clin. Microbiol. Open Access 4, 6 (2017).","journal-title":"Clin. Microbiol. Open Access"},{"key":"38449_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0005-2736(97)00051-5","volume":"1327","author":"K Matsuzaki","year":"1997","unstructured":"Matsuzaki, K., Sugishita, K., Harada, M., Fujii, N. & Miyajima, K. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta BBA Biomembr. 1327, 119\u2013130 (1997).","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"38449_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1086\/502522","volume":"26","author":"SE Cosgrove","year":"2005","unstructured":"Cosgrove, S. E. et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect. Control Hosp. Epidemiol. 26, 166\u2013174 (2005).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"38449_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389\u2013395 (2002).","journal-title":"Nature"},{"issue":"2","key":"38449_CR16","first-page":"120","volume":"27","author":"M Mani","year":"2020","unstructured":"Mani, M. et al. Clinical applications of antimicrobial peptides (AMPs): Where do we stand now?. Protein Pept. Lett. 27(2), 120\u2013134 (2020).","journal-title":"Protein Pept. Lett."},{"key":"38449_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","volume":"54","author":"MJ Roberts","year":"2002","unstructured":"Roberts, M. J., Bentley, M. D. & Harris, J. M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54, 459\u2013476 (2002).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"38449_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2021.183806","volume":"1864","author":"SR Dennison","year":"2022","unstructured":"Dennison, S. R. et al. PEGylation enhances the antibacterial and therapeutic potential of amphibian host defence peptides. Biochim. Biophys. Acta BBA Biomembr. 1864, 183806 (2022).","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"38449_CR19","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1128\/AAC.06335-11","volume":"56","author":"CJ Morris","year":"2012","unstructured":"Morris, C. J. et al. Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery. Antimicrob. Agents Chemother. 56, 3298\u20133308 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"38449_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","volume":"161","author":"G Pasut","year":"2012","unstructured":"Pasut, G. & Veronese, F. M. State of the art in PEGylation: The great versatility achieved after forty years of research. J. Controlled Release 161, 461 (2012).","journal-title":"J. Controlled Release"},{"key":"38449_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1021\/bc050270c","volume":"17","author":"H Zhao","year":"2006","unstructured":"Zhao, H. et al. Linear and branched bicin linkers for releasable PEGylation of macromolecules: Controlled release in vivo and in vitro from mono- and multi-PEGylated proteins. Bioconjug. Chem. 17, 341\u2013351 (2006).","journal-title":"Bioconjug. Chem."},{"key":"38449_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2174\/1567201816666190201143457","volume":"16","author":"HAE Benson","year":"2019","unstructured":"Benson, H. A. E., Grice, J. E., Mohammed, Y., Namjoshi, S. & Roberts, M. S. Topical and transdermal drug delivery: From simple potions to smart technologies. Curr. Drug Deliv. 16, 444\u2013460 (2019).","journal-title":"Curr. Drug Deliv."},{"key":"38449_CR23","volume-title":"Anatomy, Skin (Integument), Epidermis","author":"H Yousef","year":"2022","unstructured":"Yousef, H., Alhajj, M. & Sharma, S. Anatomy, Skin (Integument), Epidermis (StatPearls Publishing, 2022)."},{"key":"38449_CR24","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1021\/acsabm.0c01538","volume":"4","author":"D Dutta","year":"2021","unstructured":"Dutta, D., Markhoff, J., Suter, N., Rezwan, K. & Br\u00fcggemann, D. Effect of collagen nanofibers and silanization on the interaction of HaCaT keratinocytes and 3T3 fibroblasts with alumina nanopores. ACS Appl. Biol. Mater. 4, 1852\u20131862 (2021).","journal-title":"ACS Appl. Biol. Mater."},{"key":"38449_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10616-011-9382-5","volume":"63","author":"K Jubin","year":"2011","unstructured":"Jubin, K., Martin, Y., Lawrence-Watt, D. J. & Sharpe, J. R. A fully autologous co-culture system utilising non-irradiated autologous fibroblasts to support the expansion of human keratinocytes for clinical use. Cytotechnology 63, 655\u2013662 (2011).","journal-title":"Cytotechnology"},{"key":"38449_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ja.2015.4","volume":"68","author":"I Iscla","year":"2015","unstructured":"Iscla, I. et al. A new antibiotic with potent activity targets MscL. J. Antibiot. 68, 453\u2013462 (2015).","journal-title":"J. Antibiot."},{"key":"38449_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ Van Hal","year":"2012","unstructured":"Van Hal, S. J. et al. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin. Microbiol. Rev. 25, 362\u2013386 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"38449_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbrc.2010.04.073","volume":"396","author":"LS Amer","year":"2010","unstructured":"Amer, L. S., Bishop, B. M. & van Hoek, M. L. Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Biochem. Biophys. Res. Commun. 396, 246\u2013251 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"38449_CR29","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.peptides.2011.08.018","volume":"32","author":"JH Wong","year":"2011","unstructured":"Wong, J. H. et al. Antifungal action of human cathelicidin fragment (LL13\u201337) on Candida albicans. Peptides 32, 1996\u20132002 (2011).","journal-title":"Peptides"},{"key":"38449_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4939-2999-3_5","volume-title":"Peptide Antibodies","author":"PR Hansen","year":"2015","unstructured":"Hansen, P. R. & Oddo, A. Fmoc solid-phase peptide synthesis. In Peptide Antibodies (ed. Houen, G.) 33\u201350 (Springer, 2015)."},{"key":"38449_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/macp.200700418","volume":"209","author":"T Eren","year":"2008","unstructured":"Eren, T. et al. Antibacterial and hemolytic activities of quaternary pyridinium functionalized polynorbornenes. Macromol. Chem. Phys. 209, 516\u2013524 (2008).","journal-title":"Macromol. Chem. Phys."},{"key":"38449_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.563030","volume":"11","author":"J Lu","year":"2020","unstructured":"Lu, J. et al. D- and unnatural amino acid substituted antimicrobial peptides with improved proteolytic resistance and their proteolytic degradation characteristics. Front. Microbiol. 11, 563030 (2020).","journal-title":"Front. Microbiol."},{"key":"38449_CR33","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1128\/AAC.00124-10","volume":"54","author":"M Hartmann","year":"2010","unstructured":"Hartmann, M. et al. Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob. Agents Chemother. 54, 3132\u20133142 (2010).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38449-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38449-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38449-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T02:04:40Z","timestamp":1689213880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38449-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38449"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38449-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11213"}}